memantine and homocysteine

memantine has been researched along with homocysteine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Bleich, S; Kornhuber, J; Wiltfang, J	1
Litvinenko, IV; Mogil'naya, VI; Odinak, MM; Perstnev, SV	1
Liu, J; Lu, R; Shen, J; Suo, WZ; Xiao, S; Yang, L; Zhang, B; Zhao, Z	1
Bogdanova, A; Geissmann-Ott, C; Reinhart, WH	1
Bahmanpour, S; Namavar, R; Nikbakht, F; Rastegar, K; Yeganeh, F	1
Nazıroğlu, M; Övey, İS	1

Trials

1 trial(s) available for memantine and homocysteine

Article	Year
Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2010

Article

Year

Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.

Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2

Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome

2010

Other Studies

5 other study(ies) available for memantine and homocysteine

Article	Year
Memantine in moderate-to-severe Alzheimer's disease. The New England journal of medicine, 2003, Aug-07, Volume: 349, Issue:6 Topics: Alzheimer Disease; Excitatory Amino Acid Antagonists; Homocysteine; Humans; Hyperhomocysteinemia; Memantine; N-Methylaspartate	2003
Differentiation of HT22 neurons induces expression of NMDA receptor that mediates homocysteine cytotoxicity. Neurological research, 2012, Volume: 34, Issue:1 Topics: Animals; Cell Death; Cell Differentiation; Cell Survival; Cells, Cultured; Cytotoxins; Dizocilpine Maleate; Hippocampus; Homocysteine; Memantine; Mice; Neurons; Receptors, N-Methyl-D-Aspartate	2012
Activation of N-methyl D-aspartate (NMDA) receptors has no influence on rheological properties of erythrocytes. Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4 Topics: Blood Sedimentation; Calcium Signaling; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Homocysteine; Humans; Individuality; Ion Transport; Memantine; Receptors, N-Methyl-D-Aspartate; Shear Strength; Suspensions; Viscosity	2011
Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. Journal of molecular neuroscience : MN, 2013, Volume: 50, Issue:3 Topics: Animals; Apoptosis; Benzoates; Cell Survival; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Homocysteine; Male; Memantine; Necrosis; Neuroprotective Agents; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate	2013
Effects of homocysteine and memantine on oxidative stress related TRP cation channels in Journal of receptor and signal transduction research, 2021, Volume: 41, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Calcium; Caspase 3; Caspase 9; Female; Hippocampus; Homocysteine; Male; Memantine; Membrane Potential, Mitochondrial; Mice; Models, Biological; Neurons; Oxidative Stress; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Transient Receptor Potential Channels	2021